226 related articles for article (PubMed ID: 27353564)
41. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
Sanjeev A; Mattaparthi VSK
Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
[TBL] [Abstract][Full Text] [Related]
42. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
[TBL] [Abstract][Full Text] [Related]
43. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
[TBL] [Abstract][Full Text] [Related]
44. Complexation of amyloid fibrils with charged conjugated polymers.
Ghosh D; Dutta P; Chakraborty C; Singh PK; Anoop A; Jha NN; Jacob RS; Mondal M; Mankar S; Das S; Malik S; Maji SK
Langmuir; 2014 Apr; 30(13):3775-86. PubMed ID: 24678792
[TBL] [Abstract][Full Text] [Related]
45. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein.
Kaylor J; Bodner N; Edridge S; Yamin G; Hong DP; Fink AL
J Mol Biol; 2005 Oct; 353(2):357-72. PubMed ID: 16171820
[TBL] [Abstract][Full Text] [Related]
46. Investigation of α-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T.
Sulatskaya AI; Rodina NP; Sulatsky MI; Povarova OI; Antifeeva IA; Kuznetsova IM; Turoverov KK
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142878
[TBL] [Abstract][Full Text] [Related]
47. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
[TBL] [Abstract][Full Text] [Related]
48. Cu(II) promotes amyloid pore formation.
Zhang H; Rochet JC; Stanciu LA
Biochem Biophys Res Commun; 2015 Aug; 464(1):342-7. PubMed ID: 26129772
[TBL] [Abstract][Full Text] [Related]
49. Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.
Yang J; Hu J; Zhang G; Qin L; Wen H; Tang Y
J Mol Model; 2021 Aug; 27(9):260. PubMed ID: 34432157
[TBL] [Abstract][Full Text] [Related]
50. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
Kardani J; Roy I
ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
[TBL] [Abstract][Full Text] [Related]
51. Single fibril growth kinetics of α-synuclein.
Wördehoff MM; Bannach O; Shaykhalishahi H; Kulawik A; Schiefer S; Willbold D; Hoyer W; Birkmann E
J Mol Biol; 2015 Mar; 427(6 Pt B):1428-1435. PubMed ID: 25659910
[TBL] [Abstract][Full Text] [Related]
52. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals.
Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM
Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotective and nootropic drug noopept rescues α-synuclein amyloid cytotoxicity.
Jia X; Gharibyan AL; Öhman A; Liu Y; Olofsson A; Morozova-Roche LA
J Mol Biol; 2011 Dec; 414(5):699-712. PubMed ID: 21986202
[TBL] [Abstract][Full Text] [Related]
54. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
Rekas A; Ahn KJ; Kim J; Carver JA
Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
[TBL] [Abstract][Full Text] [Related]
55. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract.
Shaltiel-Karyo R; Davidi D; Frenkel-Pinter M; Ovadia M; Segal D; Gazit E
Biochim Biophys Acta; 2012 Oct; 1820(10):1628-35. PubMed ID: 22575665
[TBL] [Abstract][Full Text] [Related]
56. Vibrational Circular Dichroism Sheds New Light on the Competitive Effects of Crowding and β-Synuclein on the Fibrillation Process of α-Synuclein.
Van de Vondel E; Baatsen P; Van Elzen R; Lambeir AM; Keiderling TA; Herrebout WA; Johannessen C
Biochemistry; 2018 Oct; 57(41):5989-5995. PubMed ID: 30239196
[TBL] [Abstract][Full Text] [Related]
57. Deciphering the anti-Parkinson's activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K.
Panigrahi GP; Rane AR; Vavilala SL; Choudhary S
J Biochem; 2019 Dec; 166(6):463-474. PubMed ID: 31385584
[TBL] [Abstract][Full Text] [Related]
58. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
59. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
[TBL] [Abstract][Full Text] [Related]
60. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity.
Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK
Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
